The BAD’s Clinical Standards Unit is seeking to appoint additional guideline development group (GDG) members for updating the BAD’s 2017 clinical guideline for managing people with pemphigus vulgaris (Harman et al.).

Membership of the GDG is open to consultants and trainees. We would welcome applications from members with expertise in pemphigus vulgaris, evidence-based medicine and/or guideline development.

The development of all BAD guidelines follows the GRADE methodology, therefore, as part of this and our continued adherence to the NICE Accreditation criteria, there is a requirement to ensure that at least 51% of GDG members must be without certain types of interests.  Please refer to the BAD’s policy for declaration of interests for guideline authors for information, including the categories of interests, washout period, the conditions/exclusions, and then make your declarations as part of your application. All declarations of interests will be considered individually and as a group to ensure compliance with the aforementioned BAD policy. Applicants should also be aware that all GDG members are advised not to incur further interests throughout the duration of the project to enable full participation. 

Please declare your interests, and then submit an email application detailing relevant experience and publications, with a two-page CV, to the BAD Director of Clinical Standards, Dr M. Firouz Mohd Mustapa (firouz@bad.org.uk) by Monday 16 June 2025. Currently, it is envisaged that the first GDG meeting will take place in Q4 2025.